San Diego-based Gossamer Bio, which in July snagged a $230 million series B round, recently announced the hire of a former executive from pharmaceutical giant Bristol-Myers Squibb.
Not many biotechs in San Diego both develop drugs and commercialize them.
A New York investment management firm has pledged $65 million to a new venture with UC San Diego to bridge the divide between basic research and clinical trials.
Dr. Patricio “Patrick” A. Frias’ is a physician-turned-executive, a path that helped land a new gig as the president and CEO of Rady Children’s Hospital and Health Center.
Inscripta has purchased Solana Biosciences, a San Diego company led by former Illumina veterans that specializes in genomics manufacturing operations.
San Diego-based ResMed has filed a patent infringement petition that is seeking to ban the U.S. import and sale of select breathing masks from New Zealand-based Fisher & Paykel.
BIOTECH: Oral Drug Replaces Shot, Aims for Greater Efficacy
After early years operating on a shoestring budget, Crinetics Pharmaceuticals is flush with cash to pursue ambitious drug development plans.
The U.S. Food and Drug Administration on Aug. 26 declined to approve Waylivra, a drug from Ionis Pharmaceuticals targeting an ultra-rare disease.
Illumina notched approval from the China National Drug Administration to market and sell its MiSeqDx sequencing system to hospitals and other medical institutions throughout the country.
When scouting where to consolidate San Diego operations, Takeda Pharmaceuticals put together a checklist. Most pressing: a plot that could accommodate 300 employees, near research institutions and other life science companies.
Shares of Ionis Pharmaceuticals and spinout Akcea Therapeutics kept falling Tuesday morning after a U.S. Food and Drug Administration division failed to sign off on their drug Waylivra.
The J. Craig Venter Institute filed a motion to dismiss a lawsuit alleging that its CEO, J. Craig Venter, took trade secrets from former employer Human Longevity.
Rakuten Aspyrian hauled in a $150 million Series C round as the company’s lead cancer candidate moves into a final-stage trial.
BIOTECH: Genomics Giant Does Trailblazing In Real Estate, Too
Illumina keeps outgrowing its digs, which becomes evident looking at the UTC landscape.
Dthera Sciences’ device intended for Alzheimer’s patients has received a breakthrough designation that will speed regulatory review.
Dr. Christopher Kane will lead the charge to expand primary care access, among other goals, in new roles as dean of clinical affairs for UC San Diego School of Medicine and CEO of UC San Diego Health Physicians.
San Diego’s Dexcom has gained additional diabetes management technology by acquiring TypeZero Technologies. Deal terms were not disclosed.
Cash is pouring into early-stage San Diego life sciences, with 2018 shaping up as a banner year, according to observers.
Dr. Patricio “Patrick” A. Frias has been named as the new president and CEO of Rady Children’s Hospital and Health Center.
The Tri-City Healthcare District board will soon reconsider a decision to suspend operations of the center’s inpatient Behavioral Health Unit and Crisis Stabilization Unit.
DEVICES: 300 Jobs to Remain; Co. Consolidating Operations
DJO Global, which grew from a garage startup to become one of North County’s largest private employers, is laying off 187 local employees and relocating its headquarters to Dallas, Texas.
Rancho Family Medical Group, or RFMG, will be able to tap into services from UC San Diego Health through a new affiliation.
J. Craig Venter has retired as chairman of the Synthetic Genomics board, according to a company news release.
MEDICINE: National Picture Expecting 4% to 5% Growth
Four major medical device companies based in San Diego recently delivered strong quarterly results, lifting their stocks and growth outlooks.
Ferhat Ay with the La Jolla Institute for Allergy and Immunology was awarded a $2.24 million grant to for research into genetic variation and disease risk.
Rady Children’s Hospital-San Diego recently held a grand opening for a medical plaza in southwest Riverside County, with the dual goal of consolidating outpatient operations and reaching more patients.
PHARMA: Versatile Co. Takes On Cancers, Infectious Diseases
Inovio Pharmaceuticals Inc. has about 300 employees, tenfold that of 2009. Most of the scaling up occurred in the last few years to support a growing pipeline of therapies targeting cancers and infectious diseases.
In quarter two earnings, Illumina continued a streak of stomping analyst expectations.
MEDICINE: Bringing Services to the Consumer Is Trend in Health Care
Forget far-off appointments and long drives to the doctor’s office.
Competing congressional priorities are clouding the path forward for an effort to kill a 2.3 percent excise tax on medical device makers, San Diego’s NuVasive and ResMed among them.
Neurocrine’s Ingrezza — the first treatment for the nervous system disorder tardive dyskinesia — continues to rake in revenue.
San Diego-based ResMed listed fourth quarter revenue as $623.6 million, a 12 percent year-over-year increase.
San Diego-based Dexcom’s stock hit $118.57 a share the morning of Aug. 2, up sharply from closing Aug. 1 at $95.44.
Special Report: Fastest-Growing Private Companies
Kevin Lustig calls Scientist.com an overnight success story a dozen years in the making.
San Diego medical device company NuVasive reported $281.6 million in second quarter earnings, an 8.5 percent year-over-year jump.
San Diego-based Omniome, maker of a DNA sequencing platform, today announced a $60 million series B round.
BIOTECH: Sleep Apnea Venture to Be 50/50 Partnership
One has the data. The other has the analytics.
Illumina in the second quarter reported revenue of $830 million, a 25 percent year-over-year increase.
Sublimity Therapeutics, an Irish pharmaceutical in the realm of gastrointestinal and immunological diseases, has set up a Solana Beach office with six employees.
PHARMA: A $230M Funding Round, Strong Leaders Are Big Pluses
By going big, Gossamer Bio looks to break the mold.
GENOMICS: Exec Says Co. Has Cash, Runway to Next Phase
New leadership at Human Longevity is seeking to emerge from a tumultuous period of executive exodus and workforce reduction through a bid to bring its genomics-based testing center to a wider market.
Molecular diagnostic company Mesa Biotech recently notched a $20 million series B round.
Health care: Diverse Mix of Cos. Driving Patient Access to Their Records
In a maturing digital health space with an urgent need to collect disparate data, think of Seqster as something of a data locker: Patients can find health records from past caregivers, genomics reports and data from wearables like Fitbit.
The House voted July 24 to repeal a 2.3 percent excise tax on medical device makers, welcome news to San Diego’s consortium of medical device companies, including NuVasive and ResMed.
Nabriva Therapeutics has acquired San Diego-based Zavante Therapeutics, known for an antibiotic to fight infections picked up in hospitals.
One Medical, an independently held primary care practice, will open three new offices in San Diego in early 2019.
Human Longevity, or HLI, has accused the former CEO and noted geneticist, J. Craig Venter, of stealing trade secrets.
Medical device company Ra Medical recently filed paperwork for an initial public offering worth up to $86.25 million.